Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
clinical trials
fda
life sciences
national
2
×
national blog main
san francisco blog main
san francisco top stories
2
×
abaloparatide
abeona therapeutics
achaogen
affordable care act
alnylam pharmaceuticals
alzheimer's
astrazeneca
biosimilar
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
brexanolone
celiac disease
chris collins
coherus biosciences
cydan development
deals
detroit blog main
detroit top stories
egfr
eli lilly
europe blog main
europe top stories
european commission
foamix pharmaceuticals
gene therapy
gop
indiana blog main
indiana top stories
johnson & johnson
What
wins
2
×
alzheimer’s
amgen
amgen’s
approval
bio
carries
congress
democrats
developed
divided
drug
elections
europe
european
fallout
heart
losses
marketing
medicine
midterm
nod
osteoporosis
panel
plenty
political
postpartum
raise
risk
roundup
search
stake
terms
took
warning
week’s
Language
unset
Current search:
wins
×
national
×
" san francisco top stories "
×
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel